Merck, a Germany-based healthcare company, has started a RMB100m (€/$13m) seed fund for startups in China after opening an innovation hub in Shanghai and plans for another one in Guangzhou this month.

Run by Merck’s overall €300m strategic corporate venturing unit and Merck China innovation hub jointly, the new seed fund will invest between €500,000 and €1m in each deal with a connection to healthcare, life science, performance materials or new businesses.

Stefan Oschmann, CEO and chairman of the executive…

James Mawson

James Mawson is founder and chief executive of Global Venturing.